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Introduction. Cancer is a major disorder physically and psychologically aﬀecting both patients and their caregivers. In this study,
health-related quality of life (HRQoL) of patient-caregiver dyads during the period of chemotherapy was assessed. Material and
Methods. Two hundred twenty-two cancer patient-caregiver dyads were enrolled in the study, which was conducted from October
2008 to March 2009. HRQoL was evaluated with EQ-5D. Results. The mean age of the sample was 57.4 and 48.9 for patients
and caregivers, respectively. The EQ-5D descriptive system indicates that female patients more frequently experience anxiety and
depression than male patients. Male and higher-education caregivers had higher VAS scores, while demographic factors did not
seem to inﬂuence patients’ HRQoL. Anxiety and depression of caregivers were correlated with patients’ problems in self-care and
usual activities. Conclusions. Quality of life is highly inﬂuenced during the period of chemotherapy for both patients and caregivers
and is often under reported. Interventions that can improve HRQoL, especially in the domain of mental health for both cancer
patients and their caregivers, need to be implemented.
1.Introduction
Cancer is one of the ﬁve leading causes of death in all age
groups in both males and females in the USA. Moreover, it is
the main cause of death among women of ages 40 to 79 years
and among men of ages 60 to 79 years. Since there has been
a notable improvement in the relative 5-year survival rates
for many cancer types and for all cancers combined [1], an
increasing interest for the impact of the disease on quality of
life of cancer patients has emerged [2–4].
Moreover, cancer is a major disorder which aﬀects not
only the patients themselves, but their family and relatives
as well. Previous research has demonstrated that caring
for patients with cancer has a considerable impact on the
caregiver [5–10]. It has been reported that being a caregiver
for a patient with cancer is associated with anxiety [5],
depression [6], sleep disturbance [7], fatigue [8], impaired
quality of life [9], impact on work, and economic burden
[10].
In order to assess the health-related quality of life
(HRQoL) of cancer patients, both generic and disease-
speciﬁc questionnaires have been applied [11]. Although
disease-speciﬁc questionnaires appeared to be more respon-
sive than generic instruments [12], there is evidence that the
sensitivity of the generic EQ-5D questionnaire is comparable
with the disease speciﬁc EORTC QLQ C-30 [13]. On the
other hand, generic questionnaires have wide applicability
across conditions and interventions. They can also be used
to compare diﬀerent cancer patient groups, cancer patients
andthegeneralpopulationorotherdiversepopulations[12].
Among the generic questionnaires available, the EQ-5D is a
widely used HRQoL instrument that has only ﬁve items and
it is easy to administer and complete [14].
The EQ-5D has been increasingly used recently in cancer
patients, and the growing body of literature provides evi-
dence to support its validity and reliability [15]. It has been
used mainly to study cancer patient groups with the same2 The Scientiﬁc World Journal
primary tumor site [16–18] and, occasionally, irrespectively
of the primary site [15, 19, 20].
The purpose of our survey was to investigate the HRQoL
of cancer patients and their caregivers during the period
of chemotherapy and to assess the impact of various
demographic parameters on the quality of life of the dyad,
using the EQ-5D.
2.MaterialsandMethods
2.1. Study Population. From October 2008 to March 2009,
two hundred twenty-two cancer patients attending the
oncology day clinic of our hospital and their accompanying
person (hereinafter designated as the “caregiver”) were
enrolled in the study. Two dedicated investigators conducted
the interview-based cross-sectional survey of the target
population.
Eligibility criteria for the patients and their caregivers
included being more than 18 years old and being physically
and mentally well to communicate with the interviewers.
Moreover, eligible patients were those with an Eastern
Cooperative Oncology Group (ECOG) performance status
between0and2[21]andbeingonactivetreatmentforeither
adjuvantorpalliativeintent.Thepatientsandtheircaregivers
provided informed consent to participate in the study.
Patients’ demographic and social characteristics (gender,
age, marital status, and educational level), disease primary
site, and comorbidities (hypertension, coronary heart dis-
ease, diabetes mellitus, and other) were also recorded by the
interviewers. Data relating to the speciﬁc patient-caregiver
relationship were also recorded (i.e., spouse, parent, or
oﬀspring, if he/she was the main caregiver and if they lived
together).
The study was approved by the ethical and scientiﬁc
committee of Attikon University Hospital, Athens, Greece.
2.2. Instrument. The EQ-5D [22] is a short, generic, HRQoL
instrument that consists of the EQ-5D descriptive system,
the EQ visual analogue scale (EQ-VAS), and the EQ-5D
utilityindex.Thedescriptivesystemassessesﬁvedimensions:
mobility, self-care, usual activities, pain/discomfort, and
anxiety/depression. Each dimension is subdivided in three
levels of severity (no complaints, some complaints, severe
complaints),andtherespondentisaskedtoindicatethemost
appropriate answer for her/his health state. This decision
results in a 1-digit number expressing the level selected for
that dimension. A combination of these answers deﬁnes the
respondent’s health-state expressed as a 5-digit health status
proﬁle. Totally, 243 (35) possible health status proﬁles are
deﬁned. On the EQ-VAS, respondents are asked to rate their
overall health state between 0 and 100 on a 20cm vertical
visual analogue scale, were 0 is the worst imaginable health
state, and 100 is the best imaginable health state. The EQ-
5D index is derived from time trade-oﬀ valuations from a
general UK population [23, 24].
The EQ-5D was found to be applicable and adaptable to
the Greek environment [25], and its construct validity was
demonstrated [26].
2.3. Statistical Analysis. Nonparametric tests (Mann-
Whitney and Kruskal-Wallis) were used to assess the
socioeconomic and clinical diﬀerences in EQ-5D VAS and
Index Scores in both patient and caregivers subgroups. The
chi-square test was applied to evaluate the diﬀerences in
response frequencies between the ﬁve dimensions of EQ-5D
in patients and their caregivers as well as to assess the gender
diﬀerences in the ﬁve EQ-5D dimensions. Spearman test
was used to ﬁnd out relationships between patients and
caregivers HRQoL dimensions of EQ-5D. Results were
considered statistically signiﬁcant when P<0.05, and all
analyses were performed using SPSS v16.0.
3. Results
Of the 222 eligible patient-caregiver dyads, 212 ﬁnally
participatedinthestudy(responserate96.5%).Fromtherest
of the cases, six relatives and four patients were reluctant to
participate. Patients’ and caregivers’ sociodemographic and
clinical characteristics, as well as the mean EQ-5D VAS and
Index Scores, are presented in Tables 1 and 2,r e s p e c t i v e l y .
The mean age of the study participants was 57.4 years ±14.6
(M ± SD) for the patients and 48.9 years ±14.3 for the
caregivers, and the majority was females (56.1% and 62.7%,
resp.). 170 patients (80.2%) and 160 caregivers (75.5%)
were married, while 120 patients (56%) and 168 caregivers
(79.2%) had secondary and higher education, respectively.
Gastrointestinal (26.9%) and urogenital (21.7%) malignan-
cies were the most prevalent cancer types followed by breast
(18.4%),respiratory(15.6%),andhead/neckcancers(5.7%).
Caregivers lived in the same house and were the “main
caregiver” in 73.1% of the cases, whereas in 46% of the cases
was a spouse.
Distribution of EQ-5D dimensions (mobility, self-care,
usual activities, pain/discomfort, and anxiety/depression) of
the patients and the caregivers are summarized in Table 3.
Comparing the HRQoL of male and female patients, we
observed that female patients were more likely to have
anxiety/depression (χ2 = 17.4, P<0.001), whereas, for
caregivers, we found that female caregivers’ HRQoL was
worse in the dimensions of mobility (χ2 = 3.98, P =
0.046), pain/discomfort (χ2 = 14.96, P = 0.001), and
anxiety/depression (χ2 = 8.78, P = 0.012) (Table 4).
The correlation between patients’ and caregivers’ HRQL
indicated that problems in patients’ dimensions of self-care
andusualactivitieshadanegativeinﬂuenceinthedimension
of anxiety/depression of the caregivers (P = 0.039 and P =
0.033, resp.).
The most prevalent health proﬁles, out of a total of 243
possible health states for the patients and their caregivers,
are described in Table 5. The most frequent health state
of both patients and caregivers was 11112 that indicates
moderateanxietyordepressionandnoproblemsintheother
dimensions (14.6% and 48.1%, resp.), followed by the health
state 11111 that indicates no problems in any of the ﬁve
dimensions (9.9% and 16.5%, resp.).The Scientiﬁc World Journal 3
Table 1: Patients’ sociodemographic and clinical characteristics and EQ-5D VAS and Index Scores.
N (%) VAS ± 1SD EQ-5Dindex ± 1SD
Gender
Females 119 (56.1) 64.7 ±22.70 .612 ±0.341
Males 93 (43.9) 68.9 ±20.40 .707 ±0.318
P∗ 0.268 0.017
Age
Mean 57.4
Range 18–81
Marital status
Married 170 (80.2) 66.6 ±22.40 .637 ±0.350
Unmarried 19 (9.0) 65.7 ±21.10 .718 ±0.252
Divorced 5 (2.6) 57.0 ±19.20 .763 ±0.182
Widowed 14 (6.6) 68.6 ±17.40 .683 ±0.292
P∗∗ 0.686 0.936
Education
Primary 77 (36.3) 68.4 ±21.70 .612 ±0.360
Secondary 74 (34.9) 65.1 ±21.70 .659 ±0.336
Technological education institution 18 (9.1) 69.7 ±23.90 .666 ±0.338
University 28 (14.2) 63.7 ±18.90 .750 ±0.219
P∗∗ 0.664 0.579
Comorbidity
Hypertension
Yes 63 (29.7) 68.9 ±21.20 .62 ±0.34
No 149 (69.3) 65.6 ±22.11 0.66 ±0.33
P∗ 0.443 0.468
Coronary Heart disease
Yes 27 (12.7) 73.3 ±19.00 .61 ±0.35
No 185 (86.3) 65.6 ±22.10 .65 ±0.33
P∗ 0.151 0.775
Diabetes mellitus
Yes 22 (10.4) 74.3 ±20.90 .58 ±0.32
No 190 (89.6) 65.7 ±21.80 .66 ±0.33
P∗ 0.088 0.145
Cancer site
Gastrointestinal 57 (26.9) 66.3 ±22.50 .60 ±0.38
Urogenital 46 (21.7) 65.9 ±22.60 .61 ±0.29
Breast 39 (18.4) 66.3 ±20.30 .69 ±0.29
Respiratory 33 (15.6) 68.2 ±22.70 .63 ±0.40
Head and neck 12 (5.7) 70.4 ±19.10 .85 ±0.13
Other 25 (11.8) 65.1 ±22.30 .68 ±0.29
P∗∗ 0.861 0.166
∗Mann-Whitney; ∗∗Kruskal Wallis.
4. Discussion
It is well documented [27–29] that HRQoL in general
population, as it is measured with the EQ-5D, is inﬂuenced
by sociodemographic diﬀerences like gender, educational
level, and marital status. Fewer problems on the descriptive
system and higher scores on the visual analogue scale are
most prevalent in males, higher-educational-level groups,
and married people.
In our study, according to the subjective state of health
recorded on the visual analogue scale, male and higher-
education caregivers had higher VAS scores. Interestingly,
married caregivers had lower VAS scores than single ones
in contrast with the general population’s observations. This
can be explained by the fact that the higher proportion of
caregivers in the current study was spouses of the patients
with whom they were living with in the same house and
caring for. According to Nijboer et al. [30], being a partner of4 The Scientiﬁc World Journal
Table 2: Caregivers’ sociodemographic and clinical characteristics, EQ-5D VAS, and Index Scores.
N (%) VAS ± 1SD EQ-5Dindex ± 1SD
Gender
Females 133 (62.7) 69.6 ±21.80 .783 ±0.228
Males 79 (37.3) 75.9 ±14.90 .895 ±0.141
P∗ 0.023 <0.001
Age
Mean 48.9
Range 20–80
Marital status
Married 160 (75.5) 71.17 ±18.70 .831 ±0.201
Unmarried 36 (17.0) 79.4 ±18.60 .865 ±0.173
Divorced 8 (3.8) 70.7 ±19.20 .750 ±0.256
Widowed 6 (2.8) 55.8 ±26.20 .695 ±0.267
P∗∗ 0.018 0.177
Education
Primary 30 (14.2) 66.3 ±19.50 .872 ±0.166
Secondary 91 (42.9) 71.2 ±20.10 .813 ±0.209
Technological educational institution 33 (16.7) 73.3 ±16.60 .851 ±0.169
University 44 (22.3) 80.1 ±11.90 .827 ±0.209
P∗∗ 0.009 0.493
Comorbidity
Hypertension
Yes 37 (17.5) 67.43 ±23.44 0.83 ±0.22
No 175 (82.5) 74.94 ±18.74 0.82 ±0.20
P∗ 0.206 0.588
Coronary Heart disease
Yes 14 (6.6) 61.07 ±28.22 0.78 ±0.27
No 198 (93.4) 72.94 ±18.74 0.82 ±0.20
P∗ 0.141 0.481
Diabetes mellitus
Yes 11 (5.2) 57.27 ±27.32 0.80 ±0.30
No 201 (94.8) 72.78 ±18.96 0.82 ±0.20
P∗ 0.048 0.570
Relationship
Spouse 98 (46.2) 71.4 ±19.40 .84 ±0.19
Parent 40 (18.9) 71.4 ±24.80 .80 ±0.23
Oﬀspring 47 (22.2) 76.5 ±15.30 .85 ±0.16
Other 27 (12.7) 67.0 ±18.60 .75 ±0.25
P∗∗ 0.183 0.367
Main caregiver
Yes 155 (73.1) 70.5 ±20.10 .82 ±0.21
No 57 (26.9) 79.6 ±16.00 .84 ±0.18
P∗ 0.009 0.686
Living in the same house
Yes 155 (73.1) 70.6 ±20.60 .82 ±0.20
No 57 (26.9) 75.6 ±16.60 .82 ±0.21
P∗ 0.113 0.800
∗Mann-Whitney; ∗∗Kruskal Wallis.The Scientiﬁc World Journal 5
Table 3: Patients’ and caregivers’ EQ-5D dimension scores.
Patients Caregivers
N (%) N (%)
Mobility
No diﬃculties 137 (64.6) 201 (94.8)
Some diﬃculties 68 (32.1) 11 (5.2)
Extreme diﬃculties 7 (3.3) 0 (0)
P χ2 = 60.24; df = 2; P<0.001
Self-care
No diﬃculties 171 (80.7) 210 (99.1)
Some diﬃculties 34 (16.0) 2 (0.9)
Extreme diﬃculties 7 (3.3) 0 (0)
P χ2 = 39.43; df = 2; P<0.001
Usual activities
No diﬃculties 105 (49.5) 196 (92.5)
Some diﬃculties 89 (42.0) 16 (7.5)
Extreme diﬃculties 18 (8.5) 0 (0)
P χ2 = 96.26; df = 2; P<0.001
Pain/discomfort
No diﬃculties 99 (46.7) 173 (81.6)
Some diﬃculties 88 (41.5) 38 (17.9)
Extreme diﬃculties 25 (11.8) 1 (0.5)
P χ2 = 62.13; df = 2; P<0.001
Anxiety/depression
No diﬃculties 55 (25.9) 42 (19.8)
Some diﬃculties 122 (57.5) 127 (59.9)
Extreme diﬃculties 35 (16.5) 43 (20.3)
P χ2 = 2.76; df = 2; P = 0.259
df: degrees of freedom.
acarerecipient,ascomparedtoothercaregivers,isassociated
with experiencing more strain, potentially becoming ill, and
experiencing higher levels of psychiatric symptoms.
Onthecontrary,thesemonitoredfactors(gender,marital
status, and educational level) had no inﬂuence on the
subjective health condition of the patients, as recorded by
the EQ-VAS scores in the present study. Similarly, Slovacek
et al. [31] reported that the inﬂuence of these factors on
EQ-5D VAS, in patients who have undergone hematopoietic
stem cell transplantation, was not proven to be statistically
signiﬁcant. Another study of men with prostate cancer has
reported the absence of a signiﬁcant association between
marital status and the EQ-5D VAS [32].
The EQ-5D item responses indicate that female patients
experience more frequently anxiety or depression than male
patients. Previous studies have demonstrated high levels
of depression and anxiety in cancer patients. No gender
diﬀerences for anxiety [33, 34] and depression [34, 35], a
higher prevalence of anxiety [35–38] or depression [38, 39]
in women or a higher prevalence of depression in men [40],
have been reported in various studies. On the other hand,
HRQoL of female caregivers was worse than that of males in
all ﬁve dimensions of the EQ-5D descriptive system and this
was shown to be statistically signiﬁcant for three dimensions.
Caregiving is physically and emotionally demanding, and
gender diﬀerences, in self-reported caregivers’ physical and
psychological health, have been widely reported in previous
studies [9, 41–43].
Cancer patients and their caregivers had statistically
signiﬁcant diﬀerences in all but one EQ-5D dimension
(Table 3). Despite that a higher proportion of caregivers
experienced moderate or extreme anxiety or depression
(80.2%) than patients did (74%), this was not statistically
signiﬁcant. Likewise, previous studies have noted higher
rates of psychological problems in caregivers as compared
with patients. In a study of gastrointestinal and lung cancer
patients [44], symptoms of depression were reported in
38.9% of the caregivers and in 23% of their ill spouses. In
anotherstudyofpatientswithbraintumors[45],thespouses
of the patients were more psychologically aﬀected than the
patients (47% and 38%, resp.). Moreover, Bambauer et al.
[46] demonstrated that the presence of anxiety disorders
in one member of the dyad increased the likelihood of an
anxiety disorder to the partner. Similarly, Fleming et al. [47]
have reported a correlation between advanced metastatic
cancerpatients’ and caregivers’ mental healthand depression
scores.
As expected, caregivers’ anxiety and depression were
highly correlated with patients’ problems in self-care and6 The Scientiﬁc World Journal
Table 4: Intragender diﬀerences in patients’ and caregivers’ EQ-5D dimensions.
Patients Caregivers
Males Females Males Females
N (%) N (%) N (%) N (%)
Mobility
No diﬃculties 63 (67.7) 74 (62.2) 78 (98.7) 123 (92.5)
Some diﬃculties 29 (31.2) 39 (32.8) 1 (1.3) 10 (7.5)
Extreme diﬃculties 1 (1.1) 6 (5.0) 0( 0 ) 0( 0 )
χ2 = 2.78; df = 2; P = NS χ2 = 3.98; df = 2; P = 0.046
Self-care
No diﬃculties 77 (82.8) 94 (79.0) 79 (100) 131 (98.5)
Some diﬃculties 12 (12.9) 22 (16.5) 0 (0) 2 (1.5)
Extreme diﬃculties 4 (4.3) 3 (2.5) 0( 0 ) 0( 0 )
χ2 = 1.61; df = 2; P = NS χ2 = 1.21; df = 1; P = NS
Usual activities
No diﬃculties 47 (50.5) 58 (48.7) 76 (96.2) 120 (90.2)
Some diﬃculties 41 (44.1) 48 (40.3) 3 (3.8) 13 (9.8)
Extreme diﬃculties 5 (5.4) 13 (10.9) 0( 0 ) 0( 0 )
χ2 = 2; df = 2; P = NS χ2 = 2.58; df = 1; P = NS
Pain/discomfort
No diﬃculties 45 (48.4) 54 (45.8) 75 (94.9) 98 (73.7)
Some diﬃculties 35 (37.6) 53 (44.5) 4 (5.1) 34 (25.6)
Extreme diﬃculties 13 (14.0) 12 (10.1) 0 (0) 1 (0.8)
χ2 = 1.37; df = 2; P = NS χ2 = 14.96; df = 2; P = 0.001
Anxiety/depression
No diﬃculties 34 (36.6) 21 (17.6) 20 (25.3) 22 (16.5)
Some diﬃculties 53 (57.0) 69 (58.0) 51 (64.6) 76 (57.1)
Extreme diﬃculties 6 (6.5) 29 (24.4) 8 (10.1) 35 (26.3)
χ2 = 17.4; df = 2; P<0.001 χ2 = 8.78; df = 2; P = 0.012
df: degrees of freedom.
Table 5: The most prevalent health proﬁles of the patients and their caregivers.
Patients’ health state Frequency (%) Caregivers’ health state Frequency (%)
11112 31 (14.6) 11112 102 (48.1)
11111 21 (9.9) 11111 35 (16.5)
11122 21 (9.9) 11113 29 (13.7)
11212 11 (5.2) 11122 12 (5.7)
21222 10 (4.7) 11121 6 (2.8)
11113 8 (3.8) 11123 6 (2.8)
11121 8 (3.8) 11212 4 (1.9)
21212 8 (3.8) 21223 3 (1.4)
usual activities. These ﬁndings support previous study ﬁnd-
ingsthatcaregivers’depressionandpatients’disabilitytoper-
form their daily activities are highly related. Emanuel et al.
have found that caregivers of terminally ill patients who
needed a high amount of assistance (transportation, nursing
care, homemaking, and personal care) were signiﬁcantly
more likely to have depressive symptoms than caregivers
of patients with low care needs [48]. Similarly, patients’
dependency in activities of daily living correlated with
caregivers’ depression symptoms [49]. On the other hand,
Haley et al. in a study of hospice patients with lung
cancer or dementia found that objective measures of patient
impairment or amount of care provided are not strong
predictors of caregiver depression [50]. Moreover, caregivers
who subjectively appraised caregiving tasks as less stressful
had lower depression. It is worth noting that patients’ pain
was not related with caregivers’ anxiety and depression.
Previous studies have demonstrated that patients’ symptoms
were a signiﬁcant predictor of caregiver depression [51]o r
that those caregivers of patients with cancer-related pain
scored higher for depression than caregivers of patients
without cancer-related pain [6].The Scientiﬁc World Journal 7
The diﬀerence observed between EQ-5D index and VAS,
especially in marital status, education, comorbidity, and the
type of caregiver (Table 2), has been already observed in
comparative studies concerning psychiatric disorders [52,
53]. Although both items measure quality of life, it seems
that EQ-5D index is less responsive and need larger patient
samples to detect meaningful diﬀerences compared with EQ
VAS. Nevertheless, both items seem to have equal validity in
prostate cancer patients but these results have to be validated
in further larger studies with cancer patients [54].
We are aware of the fact that our study can be limited
by some factors. First, there is a limitation associated with
the EQ-5D itself. Health-related quality of life measurement
in cancer patients is usually assessed using cancer-speciﬁc
instruments that are likely to be more responsive than
generic instruments [12]. However, in this case, a disease-
speciﬁcinstrumentwouldnotallowustomakeacomparison
between two diﬀerent populations, like cancer patients and
their relatives. Secondly, study participants were patients
and their relatives that accompanied them on the day of
chemotherapy in the oncology day clinic and not always the
main caregiver nor the person who lived in the same house,
so study ﬁndings cannot be generalized to all cancer patient-
caregiver dyads.
Despite the limitations, the present study represents an
attempt to understand the complicated interaction between
cancerpatientsundergoingchemotherapyandtheirrelatives,
in terms of their health-related quality of life. In modern
medicine, the evaluation of a patient’s health problem is
based not only on clinical or laboratory markers but also on
aholistic approachofthepatient thatincludes theevaluation
of the consequences of diagnosis or therapy of the health
condition.InterventionsthatcanimproveHRQoL,especially
in the domain of mental health, of both cancer patients and
their caregivers need to be implemented.
5. Conclusions
(i) Both cancer patients and caregivers were highly
aﬀected psychologically of the disease.
(ii) Demographic characteristics that inﬂuence the sub-
jective health status of caregivers did not appear to
inﬂuence the subjective health status of the patients.
(iii) Female patients appear to be more anxious or
depressed than males.
(iv) Anxiety and depression of caregivers were correlated
with patients’ problems in self-care and usual activi-
ties.
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